This is a medicine called Alitretinoin. It's used to treat severe eczema on the hands that doesn't respond to regular creams. It can also help with skin problems in people with AIDS.
Every report comes from a Lived member, sent anonymously.
Have you tried Alitretinoin for Kaposi Sarcoma?
Alitretinoin is a retinoid, a medicine related to vitamin A, that comes in two very different products. Panretin is a 0.1% gel applied to the skin. In the United States it is approved for adults with AIDS-related Kaposi sarcoma, a cancer linked to HIV that often appears as purple, red or brown patches or bumps on the skin. The gel treats only the lesions it is put on. It is not used when the sarcoma is spreading quickly or affecting the lungs, gut or lymph system, because those situations need systemic (whole-body) treatment, and HIV medicines remain the foundation of care. Toctino is an oral capsule used in adults with severe chronic hand eczema that has not improved with strong steroid creams. It is approved in the UK, Europe and Canada, but not in the United States. Because the gel and the capsules differ so much in how much drug reaches the body, their risks and precautions differ too, and this page notes which product each point applies to.
Retinoids act on receptors inside cells that switch genes on and off, controlling how cells grow, mature and divide. Alitretinoin is unusual in activating both main families of these receptors. In Kaposi sarcoma, this signaling slows the growth of the tumor cells in the treated patch of skin. In hand eczema, the capsules calm the immune activity that drives inflammation, reducing the chemical signals that draw inflammatory cells into the skin. Exactly why this clears eczema in some people and not others is not fully understood.
The gel is usually started twice a day, spread to cover each Kaposi sarcoma lesion fully, and increased gradually up to four times a day if the skin tolerates it. It should be kept off surrounding healthy skin and away from the eyes, mouth, nose, genitals and anus. Let it dry for three to five minutes before clothing touches it, do not cover treated areas with bandages, and wash your hands afterward unless your hands are being treated. The gel contains alcohol and is flammable, so avoid flames and smoking while applying it and right after. The capsules are taken once a day with a main meal, usually at 30 mg, with 10 mg used if side effects are hard to tolerate. A course typically lasts 12 to 24 weeks. Treatment is stopped once the hands are clear or almost clear, and stopping is considered if eczema is still severe after 12 weeks. Further courses can be given if the eczema returns. Only a dermatologist or a doctor experienced with oral retinoids should prescribe it.
With the gel, side effects mostly stay where it is applied: redness, burning or pain, itching, peeling, swelling and stinging or tingling. Some people develop a strong reaction with marked redness, swelling or blistering. If that happens, contact the care team; they may reduce how often the gel is applied or pause it until the skin settles. Treated skin is also more sensitive to sunlight. With the capsules, headache is the most common effect, especially at the 30 mg dose, along with flushing, dry skin and lips, dry eyes, and sun sensitivity. Blood tests often show higher cholesterol and triglycerides (blood fats) and changes in thyroid tests. Most of these effects are dose-related and reversible. Night vision can worsen, so take care driving in the dark. A few reactions to the capsules call for stopping the medicine and contacting the prescriber right away: depression, mood changes, aggression or unusual thoughts or behavior; a severe headache with nausea, vomiting or blurred vision, which can signal raised pressure around the brain; and severe stomach pain or severe diarrhea, which can signal inflammation of the pancreas or bowel. Thoughts of harming yourself need urgent help the same day, not just a call to the prescriber.
Alitretinoin can seriously harm a developing baby. The risk is greatest with the capsules, which can cause severe birth defects and miscarriage. Anyone who could become pregnant may take them only within a pregnancy prevention program: effective contraception starting one month before treatment, continuing throughout and for one month after the last dose, with pregnancy tests before, usually monthly during, and one month after treatment. If a period is missed or pregnancy is possible while taking the capsules or within a month after, stop the capsules and contact the prescriber right away. Breastfeeding should be avoided, and people taking the capsules should not donate blood during treatment or for one month afterward. With the gel, pregnancy status is checked before starting, and both women who could become pregnant and men with partners who could become pregnant should use effective contraception during treatment and for one week after; breastfeeding should also wait until a week after the last application. For the gel, avoid insect repellents containing DEET, because the combination increased DEET toxicity in animal studies. For the capsules, do not take tetracycline antibiotics (such as doxycycline or minocycline, often used for acne and skin infections), because together they can raise pressure around the brain, and avoid vitamin A supplements or other retinoids. Some antifungal medicines (such as ketoconazole or fluconazole), the cholesterol medicine gemfibrozil and the heart rhythm medicine amiodarone also interact, so the prescriber should review everything you take. The capsules are not used by people with liver disease, severe kidney disease, uncontrolled high blood fats or uncontrolled underactive thyroid, or an allergy to peanut or soy, which the capsules contain.
The gel works slowly. In the trials, almost no one improved in the first two weeks, about 10% had responded by four weeks and 28% by eight weeks. By 12 weeks about a third of people saw their treated lesions shrink, compared with fewer than one in six using a gel without the drug, and responses were usually partial rather than complete. New lesions appeared elsewhere in about half of people, so the gel is best seen as a way to manage visible skin lesions alongside HIV treatment, not a treatment for the sarcoma as a whole. It is continued as long as it is helping. With the capsules, about half of people with severe hand eczema reached clear or almost clear hands over 12 to 24 weeks in the main trial, compared with about one in six taking a placebo. Monitoring includes fasting blood fat tests and, for anyone who could become pregnant, monthly visits with pregnancy tests. Eczema can return after a course ends. Newer options exist: a cream called delgocitinib (Anzupgo), which blocks inflammatory signals in the skin, is FDA-approved for chronic hand eczema and outperformed oral alitretinoin in a head-to-head trial.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Alitretinoin, what you've noticed, or ask the community a question.